 BioCryst Pharmaceuticals Inc NASDAQ: BCRX has withdrawn its proposed public offering of 200 million of its stock and pre-funded warrants. The Company says that it is well-capitalized, with cash, cash equivalents, restricted cash, and investments of 222.8 million as of June 30, 2021. 